ArticleFrontiers in oncology2026

Correction: Body mass index and fasting insulin predict survival and EGFR-TKI benefit in Stage IV lung adenocarcinoma.

Huiru Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.